Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marek, Filipek"'
Autor:
Alain Ravaud, Istvan Bodrogi, Agnieszka Jagiełło-Gruszfeld, Sergio Bracarda, Piotr Koralewski, Bernard Escudier, Bohuslav Melichar, Vera Gorbunova, Christine Chevreau, Marek Filipek, Anna Pluzanska, Cezary Szczylik, Emilio Bajetta, Jacques-Olivier Bay, Nicola Moore
Publikováno v:
The Lancet. 370:2103-2111
Summary Background Vascular endothelial growth factor (VEGF) inhibition is a valid therapeutic approach in renal cell carcinoma. Therefore, an investigation of the combination treatment of the humanised anti-VEGF monoclonal antibody bevacizumab with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71f20b5f7238492312a6e80c3fcd8754
https://doi.org/10.1016/s0140-6736(07)61904-7
https://doi.org/10.1016/s0140-6736(07)61904-7
Publikováno v:
Folia medica Cracoviensia. 49(3-4)
The increase of life intensity and its stressful impact, a great number of various risk factors of ED - erectile dysfunction and aging men population lead to a high prevalence and incidence of ED worldwide. It is well known that ED in men is a condit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b3808548e497530d51ff6af551080055
https://pubmed.ncbi.nlm.nih.gov/20050580
https://pubmed.ncbi.nlm.nih.gov/20050580
Publikováno v:
Folia medica Cracoviensia. 48(1-4)
Cyclophosphamide (CYP) treatment induces chemical cystitis leading to bladder overactivity (OAB) in animals and humans. There is a great number of OAB models evaluations, which consider the bladder histology, as well as alterations in neurochemical,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e3e38c4eca17193f75924307ca63e8e0
https://pubmed.ncbi.nlm.nih.gov/19051698
https://pubmed.ncbi.nlm.nih.gov/19051698
Autor:
Marek, Worek, Marek, Filipek, Marek, Sandheim, Grzegorz, Sulimka, Marek, Niekurzak, Marcel, Mazur, Piotr J, Thor
Publikováno v:
Folia medica Cracoviensia. 48(1-4)
PCNL is an up-to-date endoscopic method of nephrolithiasis treatment, characterized by high efficacy and low invasiveness. In this study we analyze our own experiences in nephrolithiasis treatment. In St. Luke Hospital, Tarnow PCNL has been the leadi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6010dc7c75cb4898b6a865400e6319c5
https://pubmed.ncbi.nlm.nih.gov/19051695
https://pubmed.ncbi.nlm.nih.gov/19051695